Man takes 217 COVID vaccines with no ill effects, shows immune boost

FHS
March 8, 2024
3:30 am

A case report of a 62-year-old man receiving 217 SARS-CoV-2 vaccinations over 29 months reveals no adverse effects, increased T-cells, and spike-specific antibodies, providing unique insights into the effects of hyper-vaccination on immune responses.

Novel Agent Leads to Fibrosis Improvement in NASH

VIENNA – Treatment with an investigational FGF21 analogue improved fibrosis in patients with nonalcoholic steatohepatitis (NASH), according to a phase IIb trial. In the ENLIVEN

June 25, 2023

Lupin signs deal with Takeda to launch Vonoprazan in India

The agreement will allow Lupin to expand its gastroenterology portfolio in the Indian market. Credit: Orawan Pattarawimonchai/Shutterstock. Pharmaceutical company Lupin has announced a non-exclusive patent

September 19, 2024

J&J unveils PhIIa data of oral antiviral for dengue fever prevention

Johnson & Johnson’s oral antiviral has shown hints of activity in a Phase IIa human challenge trial for the prevention of mosquito-borne disease dengue fever,

October 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.